LEXARIA BIOSCIENCE CORP. Marketable Securities
LEXARIA BIOSCIENCE CORP. (LEXX) had Marketable Securities of $55.81 thousand as of 2024-08-31, per its 10-K filed 2024-11-26.
Financial Statements › Balance Sheet › Assets
us-gaap:MarketableSecurities · last filed 2024-11-26
- 2024-08-31: Marketable Securities $55.81K.
- 2024-05-31: Marketable Securities $46.31K.
- 2024-02-29: Marketable Securities $87.70K.
- 2023-11-30: Marketable Securities $72.43K.
| Period end | Marketable Securities | Marketable Securities as first filed |
|---|---|---|
| 2024-08-31 | $55.81K 10-K · filed 2024-11-26 | |
| 2024-05-31 | $46.31K 10-Q · filed 2024-07-12 | |
| 2024-02-29 | $87.70K 10-Q · filed 2024-04-09 | |
| 2023-11-30 | $72.43K 10-Q · filed 2024-01-12 | |
| 2023-08-31 | $125.64K 10-K · filed 2024-11-26 | $14.05K 10-K · filed 2023-11-20 |
| 2022-08-31 | $0.00 10-K · filed 2023-11-20 | $118.17K 10-K · filed 2022-11-28 |
| 2021-08-31 | $14.27K 10-K · filed 2022-11-28 | |
| 2021-02-28 | $468.26K 10-Q · filed 2021-04-14 | |
| 2020-05-31 | $25.00K 10-Q · filed 2020-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |